CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.   A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz Abo ...

DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom, Inc. (NASDAQ:DXCM) from $99 to $95. The analyst maintained his Buy rating on the stock. DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership Plovanic noted that fourth-quarter results and 2026 outlook met expectations, as the company’s strategy remains unchanged. Management continues to fo ...

Boston Scientific Corporation (NYSE:BSX) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 17, the price target on Boston Scientific Corporation (NYSE:BSX) was reduced from $112 to $109 by Canaccord Genuity analyst William Plovanic. The analyst reiterated his Buy rating on the stock, which still yields a revised upside potential of more than 46%. Here is Why Boston Scientific Corporation (BSX) is Highly Favored by Hedge Funds Plovanic shared his revisions fol ...

"Boring" may be just what the doctor ordered in this volatile market.Over the past few years, the exciting field of artificial intelligence (AI) has captured much of Wall Street's attention and headlines. And sure enough, some of the leaders in AI have produced incredible returns and might continue doing so. However, investors shouldn't ignore businesses that may not be as exciting, but more than make up for that with other qualities that can slowly increase wealth over time.One such company is Abbott Labor ...

New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE:BSX) concerning potential violations of the federal securities laws.On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of $890 million, appro ...

Group 1: Abbott Laboratories - Abbott Laboratories has launched a significant $20 billion debt offering through an eight-tranche deal, which includes a $3.75 billion 10-year fixed-rate tranche priced at 65 basis points over Treasuries and a $3.75 billion 30-year tranche at an 80-basis-point spread [2][3][9] - The capital raise is part of Abbott's strategy to optimize its capital structure following the acquisition of Exact Sciences, with market participants noting strong investor appetite for high-grade corporate paper [3][9] Group 2: Defense Spending - The Department of Defense has submitted a reconciliation spending plan to Congress, detailing an allocation of $151.3 billion to $153.3 billion for additional defense funding, focusing on high-end military hardware [6][7][9] - Major defense contractors such as Lockheed Martin, Northrop Grumman, and General Dynamics are expected to benefit from this surge in spending, particularly in areas like missiles, drones, and naval modernization [7][9] Group 3: Global Credit Conditions - S&P Global has issued a cautious update on global credit conditions, highlighting tariff policy uncertainty as a key risk that could destabilize markets, although it does not foresee a substantial impact on immediate U.S. credit ratings [4][5][9] - The agency describes a "K-shaped" credit environment where sectors reliant on cross-border supply chains are most vulnerable to margin compression amid escalating trade tensions [5][9] Group 4: Energy Production - North Dakota's oil production reached 1.12 million barrels per day in December, with natural gas production exceeding 3.3 million MCF, indicating resilience in energy production [11] - In the coal markets, Illinois Basin coal prices rose to $54.50 per ton, while prices in other major hubs remained unchanged [12]

Key Takeaways AngioDynamics expanded EU NanoKnife use to liver, pancreas, kidney and prostate tumors.ANGO will launch the LIVER-IRE Global Registry to assess real-world liver tumor outcomes.Europe drives 28% of global IRE volumes, supporting NanoKnife's multi-organ growth strategy.AngioDynamics (ANGO) recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical utility in soft tissue tumor ablation. The expanded approval covers NanoKnife’s use for soft tissue ablation ...

Smith provided additional drivers behind the year’s earnings growth, noting operational improvements of $30 million (or $0.86 per share), reflecting higher volume, manufacturing efficiencies, operating expense management, and acquisition performance. Interest expense was $14 million lower year over year, adding $0.33 per share after tax, while foreign exchange pressure reduced adjusted net income by $2 million (or $0.07 per share). He also noted that a higher adjusted weighted average share count reduced ad ...

For the quarter ended December 2025, Abbott (ABT) reported revenue of $11.46 billion, up 4.4% over the same period last year. EPS came in at $1.50, compared to $1.34 in the year-ago quarter.The reported revenue represents a surprise of -2.76% over the Zacks Consensus Estimate of $11.78 billion. With the consensus EPS estimate being $1.50, the EPS surprise was +0.2%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their nex ...

Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be downloaded here. In the fourth quarter of 2025, the Small Company Fund (Investor shares) fell 1.50%, behind the Russell 2000® Growth index's 1.22% gain. Real estate and telecommunications businesses led the benchmark's performance for the quarter. The Fund was down 11.46% in 2025, significantly lagging the Index’s 13.0 ...